Codiak BioSciences is offering 2.75 million shares of common stock for $57.8 million, or $21 per paper. Underwriters will be granted a 30-day option to purchase an additional 0.4125 million shares. The offer is expected to close on February 17, 2021.
Codiak BioSciences is offering 2.75 million shares of common stock for $57.8 million, or $21 per paper. Underwriters will be granted a 30-day option to purchase an additional 0.4125 million shares. The offer is expected to close on February 17, 2021. 
ir.codiakbio.com
English (US) 